Optimization of an erythroid culture system to reduce the cost of in vitro production of red blood cells-Reference-Cited by-同舟云学术

Optimization of an erythroid culture system to reduce the cost of in vitro production of red blood cells

Published:2018 Issue: Volume:5 Page:1626-1632
ISSN:2215-0161
Container-title:MethodsX
language:en
Short-container-title:MethodsX

Author:

Poldee Saiphon,Metheetrairut Chanatip,Nugoolsuksiri Sutthinee,Frayne Jan,Trakarnsanga Kongtana

Funder

Department of Health

National Institute for Health Research Blood and Transplant Unit (NIHR BTRU) in Red Blood Cell Products at the University of Bristol in Partnership with NHS Blood and Transplant

Thailand Research Fund

Publisher

Elsevier BV

Subject

Medical Laboratory Technology,Clinical Biochemistry

Reference15 articles.

1. Available from: http://www.who.int/features/factfiles/blood_transfusion/en/.

2. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells;Giarratana;Nat. Biotechnol.,2005

3. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells;Miharada;Nat. Biotechnol.,2006

4. Ex vivo large-scale generation of human red blood cells from cord blood CD34+ cells by co-culturing with macrophages;Fujimi;Int. J. Hematol.,2008

5. In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems;Dorn;Transfusion,2008

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II promotes erythroid proliferation in a three-stage erythroid culture system;MethodsX;2024-06

2. Red blood cells in biology and translational medicine: natural vehicle inspires new biomedical applications;Theranostics;2024

3. Generation of Red Blood Cells from Human Pluripotent Stem Cells—An Update;Cells;2023-06-05

4. Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro;Experimental Hematology;2023-05

5. Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system;Scientific Reports;2022-09-16